Trial
NCT04331119
Duvelisib Maintenance After Autologous Stem Cell Transplant in T-Cell Lymphomas
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Washington University School of Medicine
Collaborators
SecuraBio
Condition
T-Cell Lymphoma
Intervention
Duvelisib
Why stopped
Loss of funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-05-06